Commentary on the Women's Health Initiative

被引:14
作者
McGowan, JA
Pottern, L
机构
[1] NIAMSD, NIAMS, NIH, Bethesda, MD 20892 USA
[2] NHLBI, Bethesda, MD 20892 USA
关键词
Women's Health Initiative; postmenopausal women; heart disease; cancer; osteoporosis;
D O I
10.1016/S0378-5122(99)00109-7
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The Women's Health Initiative (WHI), established by the National Institutes of Health in 1991, is a long-term national health study that focuses on strategies for preventing heart disease, breast and colorectal cancer and osteoporosis in postmenopausal women. These chronic diseases are the major causes of death, disability and frailty in older women of all races and socioeconomic backgrounds. The WHI a 15-year multi-million dollar endeavor, and one of the largest U.S. prevention studies of its kind. The study involves over 161 000 women aged 50-79, and is one of the most definitive, far reaching clinical trials of women's health ever undertaken in the U.S. The WHI Clinical Trial and Observational Study will attempt to address many of the inequities in women's health research and provide practical information to women and their physicians about hormone replacement therapy, dietary patterns and calcium/vitamin D supplements, and their effects on the prevention of heart disease, cancer and osteoporosis. Emerging information from the NIH Women's Health Initiative and other studies of women's health begun in the 1990's should be changing the landscape of options for older women in the years to come. Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:109 / 112
页数:4
相关论文
共 7 条
  • [1] Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
  • [2] VITAMIN-D(3) AND CALCIUM TO PREVENT HIP-FRACTURES IN ELDERLY WOMEN
    CHAPUY, MC
    ARLOT, ME
    DUBOEUF, F
    BRUN, J
    CROUZET, B
    ARNAUD, S
    DELMAS, PD
    MEUNIER, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (23) : 1637 - 1642
  • [3] Approaches to monitoring the results of long-term disease prevention trials: Examples from the women's health initiative
    Freedman, L
    Anderson, G
    Kipnis, V
    Prentice, R
    Wang, CY
    Rossouw, J
    Wittes, J
    DeMets, D
    [J]. CONTROLLED CLINICAL TRIALS, 1996, 17 (06): : 509 - 525
  • [4] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    Hulley, S
    Grady, D
    Bush, T
    Furberg, C
    Herrington, D
    Riggs, B
    Vittinghoff, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07): : 605 - 613
  • [5] Women's health initiative - Why now? What is it? What's new?
    Matthews, KA
    Shumaker, SA
    Bowen, DJ
    Langer, RD
    Hunt, JR
    Kaplan, RM
    Klesges, RC
    Ritenbaugh, C
    [J]. AMERICAN PSYCHOLOGIST, 1997, 52 (02) : 101 - 116
  • [6] Matthews KA, 1996, AM J EPIDEMIOL, V143, P971
  • [7] Rossouw J E, 1995, J Am Med Womens Assoc (1972), V50, P50